As the 'go-to solution' provider, we are the industry standard because of our knowledge of patent data, drug and med-tech coverage, ability to monitor related patents and access to essential patent databases.
A novel medicine is safeguarded by an active ingredient patent, also known as an active pharmaceutical ingredient patent (API), which protects the drug's structural composition. SG Analytics provides patent research services for the healthcare and medical device industries worldwide.
Medical advancements may be tracked with the use of patent databases. SG Analytics provides tech-enabled patent research and analytics services; we compile technical data according to the needs of each customer (therapeutic area, geographic region, period, etc.) and make it simple for them to access,... Read More
Healthcare and medical researchers can use SGA's patent data analytics services to determine whether or not a proposed medical invention is genuinely unique before filing a patent application. Researchers benefit from a more complete understanding of the state of the relevant technologies, reduced risk of patent infringement, and increased chances of patent approval.
Protection for a pharmaceutical patent begins upon its award and typically lasts 20 years from the patent's filing date. When examining the present situation, SGA considers not only the patent data from the past but also the future. Pharmaceutical and medical device corporations can save thousands of dollars yearly using patent information services. Our staff locates appropriate patents and patent applications based on the information and requirements supplied by SGA's clients. Depending on the client's needs, we may format our deliverables, such as alerts, newsletters, and monthly reports.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
White Papers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
White Papers
Future Trends and Technological Advances in Vaccine Treatment and Disease Prevention
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
White Papers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
CASE STUDIES
We strongly believe in equal opportunity for all. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
